# Virginia Cannabis Control Authority Warns Against Driving High > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/virginia-cannabis-control-authority-warning-driving-high/ > **Published:** 2026-04-16T12:10:44-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:20:40-04:00 > **Clinical Summary:** Virginia Cannabis Control Authority warning highlights challenges in cannabis impairment detection and driving safety with THC use. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic Public SafetyThcImpairmentPatient EducationLegal Why This Matters Cannabis impairment detection remains a significant clinical and public safety challenge, as unlike alcohol, there are no standardized roadside tests that reliably correlate THC blood levels with functional impairment. This regulatory warning highlights the gap between [cannabis legalization](https://cedclinic.com/the-forgotten-history-of-hemp-in-america/) and evidence-based impairment assessment tools. Clinical Summary Virginia’s Cannabis Control Authority has issued warnings about driving under cannabis influence, reflecting ongoing challenges in cannabis impairment detection and public safety policy. THC affects psychomotor function, reaction time, and cognitive processing, but impairment varies significantly based on tolerance, consumption method, timing, and individual factors. Current detection methods cannot reliably determine real-time functional impairment, unlike breath alcohol testing which correlates well with intoxication levels. Dr. Caplan’s Take “I counsel patients that cannabis impairment is real but unpredictable — your tolerance doesn’t make you safe to drive, and there’s no reliable way to self-assess when impairment has cleared. The safest approach remains waiting several hours after any [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) before driving.” Clinical Perspective 🧠 Clinicians should discuss impairment timelines with cannabis patients, emphasizing that effects can persist beyond subjective awareness of intoxication. Patients need clear guidance that legal [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) still carries legal and safety risks when driving, and that tolerance does not eliminate impairment or legal liability. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Virginia%20Cannabis%20Control%20Authority%20warns%20against%20driving%20high%20-%20WAVY.com%20%40drcaplan&url=https%3A//www.wavy.com/marijuana-in-virginia/virginia-cannabis-control-authority-warns-against-driving-high/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.wavy.com/marijuana-in-virginia/virginia-cannabis-control-authority-warns-against-driving-high/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Virginia%20Cannabis%20Control%20Authority%20warns%20against%20driving%20high%20-%20WAVY.com%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.wavy.com/marijuana-in-virginia/virginia-cannabis-control-authority-warns-against-driving-high/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.wavy.com/marijuana-in-virginia/virginia-cannabis-control-authority-warns-against-driving-high/](https://www.wavy.com/marijuana-in-virginia/virginia-cannabis-control-authority-warns-against-driving-high/) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance level of this cannabis news?](#What_is_the_clinical_relevance_level_of_this_cannabis_news) - [What are the main safety concerns related to THC and impairment?](#What_are_the_main_safety_concerns_related_to_THC_and_impairment) - [Why is patient education important regarding cannabis impairment?](#Why_is_patient_education_important_regarding_cannabis_impairment) - [How should healthcare providers address cannabis-related impairment with patients?](#How_should_healthcare_providers_address_cannabis-related_impairment_with_patients) - [What makes this cannabis impairment topic noteworthy for clinical practice?](#What_makes_this_cannabis_impairment_topic_noteworthy_for_clinical_practice) - [Related](#Related) ## FAQ #### What is the clinical relevance level of this cannabis news? This article has been assigned CED Clinical Relevance #70, indicating “Notable Clinical Interest.” This classification means the findings or policy developments are emerging and worth monitoring closely by healthcare professionals. #### What are the main safety concerns related to THC and impairment? THC can cause significant impairment affecting motor skills, reaction time, and [cognitive function](https://cedclinic.com/reverse-cholesterol-transport-function-cannabis-users/). This creates public safety risks, particularly when patients operate vehicles or machinery after cannabis use. #### Why is patient education important regarding cannabis impairment? Patients need to understand how THC affects their ability to perform daily activities safely. Proper education helps patients make informed decisions about timing of use and avoiding potentially dangerous situations while impaired. #### How should healthcare providers address cannabis-related impairment with patients? Providers should discuss onset times, duration of effects, and individual variation in THC response. Clear guidelines about avoiding driving and other safety-sensitive activities should be established as part of treatment planning. #### What makes this cannabis impairment topic noteworthy for clinical practice? The intersection of [cannabis therapeutics](https://cedclinic.com/firearms-regulatory-guidance-cannabis/) and public safety represents an evolving area requiring careful clinical consideration. As cannabis use increases, healthcare providers must balance [therapeutic benefits](https://cedclinic.com/therapeutic-benefits-of-thc/) with safety risks and legal implications. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Virginia agency launches campaign against driving after using cannabis – WVTF](https://cedclinic.com/cannabis-impaired-driving-risks-safety-campaign-virginia/) Learn about Virginia's efforts to reduce cannabis-impaired driving through public awareness campaigns. [Read More](https://cedclinic.com/cannabis-impaired-driving-risks-safety-campaign-virginia/) [Cannabis and Driving? Studies Reveal Big Risks](https://cedclinic.com/cannabis-impaired-driving-risks/) Explore research findings on the risks associated with cannabis use and driving impairment. [Explore Research](https://cedclinic.com/cannabis-impaired-driving-risks/) [Feds Launch Campaign Warning Against Marijuana-Impaired Driving Ahead Of 4/20](https://cedclinic.com/marijuana-impaired-driving-federal-campaign-4-20-warning/) Federal initiatives focus on preventing marijuana-impaired driving with targeted campaigns. [Learn More](https://cedclinic.com/marijuana-impaired-driving-federal-campaign-4-20-warning/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).